8-K - AbCellera Biologics Inc. | StockGist

Current Report Details

Event Type

Financial Results

Regulation Fd

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

2.02

Results of Operations and Financial Condition On February 24, 2026, AbCellera Biologics Inc. (the “Company”), issued a press release announcing its financial an

Financial Results

7.01

Regulation FD In connection with its earnings call on February 24, 2026, to discuss its results for the year ended December 31, 2025, the Company will utilize a

Regulation Fd

9.01

Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 99.1 Press Release issued by AbCellera Biologics Inc. on February 24 , 2026. 99.2 Corpora

Exhibits Only

Source Document

Exhibits (3)

8-K

99.1

EX-99.1

99.2

EX-99.2